Dujardin, Kathy

Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study

Moss, D. J. H., Pardiñas, A. F., Langbehn, D., Lo, K., Leavitt, B. R., Roos, R., Durr, A., Mead, S., Coleman, A., Santos, R. D., et al. (2017) · The Lancet Neurology

Genetic Neurodegenerative DiseasesGenetic Associations and Epidemiology

Cited by 312

The Parkinson Anxiety Scale (PAS): Development and validation of a new anxiety scale

Leentjens, A. F. G., Dujardin, K., Pontone, G. M., Starkstein, S. E., Weintraub, D., & Martinez‐Martin, P. (2014) · Movement Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesPsychometric Methodologies and Testing

Cited by 270

Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross‐sectional study

Leentjens, A. F. G., Dujardin, K., Marsh, L., Martinez‐Martin, P., Richard, I. H., & Starkstein, S. E. (2011) · Movement Disorders

Parkinson's Disease Mechanisms and TreatmentsAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 173

REM sleep modifications following a Morse code learning session in humans

Mandai, O., Guerrien, A., Sockeel, P., Dujardin, K., & Leconte, P. (1989) · Physiology & Behavior

Sleep and Wakefulness ResearchSleep and related disorders

Cited by 93

Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial

Moonen, A. J. H., Mulders, A. E. P., Defebvre, L., Duits, A., Flinois, B., Köhler, S., Kuijf, M. L., Leterme, A., Servant, D., de Vugt, M., et al. (2021) · Movement Disorders

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesParkinson's Disease Mechanisms and Treatments

Cited by 71

Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations

Vignando, M., ffytche, D., Lewis, S. J. G., Lee, P. H., Chung, S. J., Weil, R. S., Hu, M. T., Mackay, C. E., Griffanti, L., Pins, D., et al. (2022) · Nature Communications

Hallucinations in medical conditionsParkinson's Disease Mechanisms and Treatments

Cited by 42